Front Row Advisors LLC Viatris Inc Transaction History
Front Row Advisors LLC
- $250 Million
- Q1 2025
A detailed history of Front Row Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 11 shares of VTRS stock, worth $99. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 11
-0.0%
Holding current value
$99
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.31 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$838 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$673 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$587 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$556 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...